Latest Bioenergy News

Delorean Corporation has released its audited 2025 Annual Report, revealing key adjustments from its preliminary results including lower revenue, increased tax expenses, and a significant reclassification of borrowings.

Delorean Corporation has locked in a $14.5 million lower-cost loan facility with National Australia Bank to fund its SA1 Salisbury Bioenergy Project, refinancing existing debt and freeing capital for further bioenergy developments.

Delorean Corporation has locked in a long-term biomethane supply agreement with Origin Energy, underpinning its SA1 Salisbury bioenergy project with up to $40 million in revenue over 10 years.

Delorean Corporation reveals a strategic shift from EPC contractor to owner-operator of bioenergy assets, unveiling a $500 million-plus project portfolio despite a FY25 revenue dip and loss. The company is positioning itself at the forefront of Australia’s renewable gas market.

Delorean Corporation reported a strategic shift in FY25, transitioning from third-party bioenergy construction to owning and operating renewable gas infrastructure, resulting in a $4.1 million loss but positioning the company for future multi-revenue growth.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Delorean Corporation stands to benefit significantly from recent Australian regulatory reforms that formally recognise biomethane as a natural gas equivalent, enhancing the commercial viability of its renewable gas projects.

Nufarm reported a mixed 1H25 with a strong rebound in crop protection profits contrasting a sharp decline in seed technologies earnings, prompting a strategic review of the latter business.

Nufarm Limited reported a 3% revenue increase to $1.81 billion for the half-year ended March 2025, driven by Crop Protection volume growth. However, net profit after tax fell 39% amid fish oil pricing pressures and higher operating costs, prompting the board to withhold an interim dividend.

Nufarm Limited reported a solid half-year performance with a 3% revenue increase and a 40% jump in underlying EBIT, driven by strong crop protection sales and cost improvements. However, net debt rose 12%, reflecting investments in omega-3 production and seed technology expansion.

Nufarm reported a mixed 1H25 result with a strong rebound in crop protection profits contrasting a steep decline in seed technologies earnings, prompting a strategic review of the latter business.

Nufarm Limited posted a 3% revenue increase to $1.81 billion for the half-year ending March 2025, driven by Crop Protection growth, yet profits fell sharply due to omega-3 inventory write-downs and higher costs. The company withheld its interim dividend amid ongoing operational challenges.